Perrigo Announces FDA Approval Of The AB Rated Generic Version Of KlorCon® Extended-Release Tablets
Go back to Perrigo Announces FDA Approval Of The AB Rated Generic Version Of KlorCon® Extended-Release Tablets| Perrigo (NYSE: PRGO) | Delayed: 13.56 +0.08 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.48 | 52 Week High | $156.03 | |||
| Open | $13.45 | 52 Week Low | $79.72 | |||
| Day High | $13.67 | P/E | N/A | |||
| Day Low | $13.15 | EPS | $0.00 | |||
| Volume | 6,878,265 | |||||
| Perrigo (NYSE: PRGO) | Delayed: 13.56 +0.08 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.48 | 52 Week High | $156.03 | |||
| Open | $13.45 | 52 Week Low | $79.72 | |||
| Day High | $13.67 | P/E | N/A | |||
| Day Low | $13.15 | EPS | $0.00 | |||
| Volume | 6,878,265 | |||||
